Premium Nahrungsergänzungsmittel | artgerecht

Ubiquinol Synthesis Markers – Definition & Diagnostics

Ubiquinol synthesis markers are biochemical parameters used to assess the body's capacity to produce ubiquinol (reduced coenzyme Q10), a key molecule in cellular energy production and antioxidant defense.

Regular tips about health Regular tips about health

Things worth knowing about "Ubiquinol synthesis markers"

Ubiquinol synthesis markers are biochemical parameters used to assess the body's capacity to produce ubiquinol (reduced coenzyme Q10), a key molecule in cellular energy production and antioxidant defense.

What Are Ubiquinol Synthesis Markers?

Ubiquinol synthesis markers are laboratory diagnostic parameters that reflect the metabolic status and biosynthetic capacity of ubiquinol in the human body. Ubiquinol is the biologically active, reduced form of coenzyme Q10 (CoQ10), playing a central role in mitochondrial energy production and serving as a potent antioxidant. Synthesis markers help clinicians evaluate the ability of the body to adequately produce and supply ubiquinol to tissues.

Biological Basis

Ubiquinol is synthesized in the body via the mevalonate pathway, the same metabolic route responsible for cholesterol biosynthesis. Key precursors include farnesyl pyrophosphate and decaprenyl pyrophosphate. The enzyme COQ2 (polyprenyltransferase) and several other COQ enzymes (COQ3 through COQ9) are involved in the biosynthetic cascade. In the bloodstream, ubiquinol exists predominantly in its reduced form, accounting for approximately 90–95 % of the total CoQ10 pool.

Clinical Relevance of Synthesis Markers

Assessing ubiquinol synthesis markers is particularly important in the following clinical scenarios:

Statin therapy: Statins inhibit the mevalonate pathway, which can reduce endogenous CoQ10 synthesis and lead to muscle weakness (myopathy).
Primary CoQ10 deficiency: Genetic defects in COQ genes cause severe mitochondrial disorders.
Mitochondrial diseases: Impairments of the respiratory chain can be reflected by altered ubiquinol levels.
Chronic diseases: Altered CoQ10 levels have been documented in heart failure, neurodegenerative disorders, and diabetes mellitus.
Aging: Endogenous ubiquinol synthesis declines measurably with advancing age.

Key Synthesis Markers at a Glance

Ubiquinol-to-Ubiquinone Ratio

A central marker is the ratio of ubiquinol (reduced) to ubiquinone (oxidized) in blood plasma. A low ratio indicates elevated oxidative stress and an impaired reduction capacity. Under normal conditions, ubiquinol accounts for more than 90 % of the total CoQ10 pool.

Total Plasma CoQ10 Level

The total concentration of coenzyme Q10 in plasma (ubiquinol + ubiquinone) is used as a baseline marker. Reference values vary by laboratory and age, generally ranging from approximately 0.40–1.91 µmol/l (equivalent to approximately 0.34–1.65 µg/ml).

Mevalonate Pathway Intermediates

Metabolites such as mevalonate or farnesyl pyrophosphate can indirectly indicate ubiquinol biosynthetic activity and are measured in specialized laboratories.

COQ Gene Expression Markers

In molecular diagnostics, expression levels of COQ genes (e.g., COQ2, COQ6, COQ8) from blood or tissue samples can be measured to identify genetically caused biosynthetic defects.

Diagnosis and Measurement Methods

Measurement of ubiquinol and related synthesis markers is typically performed using:

HPLC (High-Performance Liquid Chromatography) with electrochemical or UV detection – the gold standard for determining ubiquinol and ubiquinone in plasma.
Mass spectrometry (LC-MS/MS) for highly precise quantitative analyses.
Genetic sequencing when primary CoQ10 deficiency is suspected, to identify mutations in COQ genes.
Enzyme activity assays in muscle biopsies or lymphocytes for mitochondrial disease evaluation.

Factors Influencing Ubiquinol Synthesis

Several factors can affect endogenous ubiquinol synthesis:

Age: Biosynthetic rates decline from approximately the third to fourth decade of life.
Medications: Statins, beta-blockers, and certain antidepressants can inhibit synthesis.
Diet: Adequate intake of precursors (e.g., tyrosine, phenylalanine, mevalonate) supports biosynthesis.
Oxidative stress: Increased oxidative stress consumes ubiquinol faster than it can be resynthesized.
Genetic variants: Polymorphisms in COQ genes can individually influence biosynthetic capacity.

References

Bhagavan, H.N. & Chopra, R.K. (2006): Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics. In: Free Radical Research, 40(5), 445–453.
Desbats, M.A. et al. (2015): Genetic bases and clinical manifestations of coenzyme Q10 (CoQ10) deficiency. In: Journal of Inherited Metabolic Disease, 38(1), 145–156.
Quinzii, C.M. & Hirano, M. (2010): Coenzyme Q and mitochondrial disease. In: Developmental Disabilities Research Reviews, 16(2), 183–188.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category